IBDEI2L4 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41250,2)
;;=^5007067
;;^UTILITY(U,$J,358.3,41251,0)
;;=I13.10^^152^2031^10
;;^UTILITY(U,$J,358.3,41251,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41251,1,3,0)
;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
;;^UTILITY(U,$J,358.3,41251,1,4,0)
;;=4^I13.10
;;^UTILITY(U,$J,358.3,41251,2)
;;=^5007068
;;^UTILITY(U,$J,358.3,41252,0)
;;=I13.11^^152^2031^11
;;^UTILITY(U,$J,358.3,41252,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41252,1,3,0)
;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
;;^UTILITY(U,$J,358.3,41252,1,4,0)
;;=4^I13.11
;;^UTILITY(U,$J,358.3,41252,2)
;;=^5007069
;;^UTILITY(U,$J,358.3,41253,0)
;;=I13.2^^152^2031^9
;;^UTILITY(U,$J,358.3,41253,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41253,1,3,0)
;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
;;^UTILITY(U,$J,358.3,41253,1,4,0)
;;=4^I13.2
;;^UTILITY(U,$J,358.3,41253,2)
;;=^5007070
;;^UTILITY(U,$J,358.3,41254,0)
;;=I15.0^^152^2031^15
;;^UTILITY(U,$J,358.3,41254,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41254,1,3,0)
;;=3^Renovascular Hypertension
;;^UTILITY(U,$J,358.3,41254,1,4,0)
;;=4^I15.0
;;^UTILITY(U,$J,358.3,41254,2)
;;=^5007071
;;^UTILITY(U,$J,358.3,41255,0)
;;=I15.1^^152^2031^3
;;^UTILITY(U,$J,358.3,41255,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41255,1,3,0)
;;=3^Hypertension Secondary to Oth Renal Disorders
;;^UTILITY(U,$J,358.3,41255,1,4,0)
;;=4^I15.1
;;^UTILITY(U,$J,358.3,41255,2)
;;=^5007072
;;^UTILITY(U,$J,358.3,41256,0)
;;=I15.2^^152^2031^2
;;^UTILITY(U,$J,358.3,41256,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41256,1,3,0)
;;=3^Hypertension Secondary to Endocrine Disorders
;;^UTILITY(U,$J,358.3,41256,1,4,0)
;;=4^I15.2
;;^UTILITY(U,$J,358.3,41256,2)
;;=^5007073
;;^UTILITY(U,$J,358.3,41257,0)
;;=I15.8^^152^2031^16
;;^UTILITY(U,$J,358.3,41257,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41257,1,3,0)
;;=3^Secondary Hypertension,Oth
;;^UTILITY(U,$J,358.3,41257,1,4,0)
;;=4^I15.8
;;^UTILITY(U,$J,358.3,41257,2)
;;=^5007074
;;^UTILITY(U,$J,358.3,41258,0)
;;=I15.9^^152^2031^17
;;^UTILITY(U,$J,358.3,41258,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41258,1,3,0)
;;=3^Secondary Hypertension,Unspec
;;^UTILITY(U,$J,358.3,41258,1,4,0)
;;=4^I15.9
;;^UTILITY(U,$J,358.3,41258,2)
;;=^5007075
;;^UTILITY(U,$J,358.3,41259,0)
;;=I16.0^^152^2031^14
;;^UTILITY(U,$J,358.3,41259,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41259,1,3,0)
;;=3^Hypertensive Urgency
;;^UTILITY(U,$J,358.3,41259,1,4,0)
;;=4^I16.0
;;^UTILITY(U,$J,358.3,41259,2)
;;=^8133013
;;^UTILITY(U,$J,358.3,41260,0)
;;=I16.1^^152^2031^7
;;^UTILITY(U,$J,358.3,41260,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41260,1,3,0)
;;=3^Hypertensive Emergency
;;^UTILITY(U,$J,358.3,41260,1,4,0)
;;=4^I16.1
;;^UTILITY(U,$J,358.3,41260,2)
;;=^8204721
;;^UTILITY(U,$J,358.3,41261,0)
;;=I16.9^^152^2031^6
;;^UTILITY(U,$J,358.3,41261,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41261,1,3,0)
;;=3^Hypertensive Crisis,Unspec
;;^UTILITY(U,$J,358.3,41261,1,4,0)
;;=4^I16.9
;;^UTILITY(U,$J,358.3,41261,2)
;;=^5138600
;;^UTILITY(U,$J,358.3,41262,0)
;;=A07.0^^152^2032^5
;;^UTILITY(U,$J,358.3,41262,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41262,1,3,0)
;;=3^Balantidiasis
;;^UTILITY(U,$J,358.3,41262,1,4,0)
;;=4^A07.0
;;^UTILITY(U,$J,358.3,41262,2)
;;=^12533
;;^UTILITY(U,$J,358.3,41263,0)
;;=A07.1^^152^2032^9
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2L4 3794 printed Apr 09, 2024@20:45:42 Page 2
IBDEI2L4 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41250,2)
+2 ;;=^5007067
+3 ;;^UTILITY(U,$J,358.3,41251,0)
+4 ;;=I13.10^^152^2031^10
+5 ;;^UTILITY(U,$J,358.3,41251,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,41251,1,3,0)
+8 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
+9 ;;^UTILITY(U,$J,358.3,41251,1,4,0)
+10 ;;=4^I13.10
+11 ;;^UTILITY(U,$J,358.3,41251,2)
+12 ;;=^5007068
+13 ;;^UTILITY(U,$J,358.3,41252,0)
+14 ;;=I13.11^^152^2031^11
+15 ;;^UTILITY(U,$J,358.3,41252,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,41252,1,3,0)
+18 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
+19 ;;^UTILITY(U,$J,358.3,41252,1,4,0)
+20 ;;=4^I13.11
+21 ;;^UTILITY(U,$J,358.3,41252,2)
+22 ;;=^5007069
+23 ;;^UTILITY(U,$J,358.3,41253,0)
+24 ;;=I13.2^^152^2031^9
+25 ;;^UTILITY(U,$J,358.3,41253,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,41253,1,3,0)
+28 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
+29 ;;^UTILITY(U,$J,358.3,41253,1,4,0)
+30 ;;=4^I13.2
+31 ;;^UTILITY(U,$J,358.3,41253,2)
+32 ;;=^5007070
+33 ;;^UTILITY(U,$J,358.3,41254,0)
+34 ;;=I15.0^^152^2031^15
+35 ;;^UTILITY(U,$J,358.3,41254,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,41254,1,3,0)
+38 ;;=3^Renovascular Hypertension
+39 ;;^UTILITY(U,$J,358.3,41254,1,4,0)
+40 ;;=4^I15.0
+41 ;;^UTILITY(U,$J,358.3,41254,2)
+42 ;;=^5007071
+43 ;;^UTILITY(U,$J,358.3,41255,0)
+44 ;;=I15.1^^152^2031^3
+45 ;;^UTILITY(U,$J,358.3,41255,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,41255,1,3,0)
+48 ;;=3^Hypertension Secondary to Oth Renal Disorders
+49 ;;^UTILITY(U,$J,358.3,41255,1,4,0)
+50 ;;=4^I15.1
+51 ;;^UTILITY(U,$J,358.3,41255,2)
+52 ;;=^5007072
+53 ;;^UTILITY(U,$J,358.3,41256,0)
+54 ;;=I15.2^^152^2031^2
+55 ;;^UTILITY(U,$J,358.3,41256,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,41256,1,3,0)
+58 ;;=3^Hypertension Secondary to Endocrine Disorders
+59 ;;^UTILITY(U,$J,358.3,41256,1,4,0)
+60 ;;=4^I15.2
+61 ;;^UTILITY(U,$J,358.3,41256,2)
+62 ;;=^5007073
+63 ;;^UTILITY(U,$J,358.3,41257,0)
+64 ;;=I15.8^^152^2031^16
+65 ;;^UTILITY(U,$J,358.3,41257,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,41257,1,3,0)
+68 ;;=3^Secondary Hypertension,Oth
+69 ;;^UTILITY(U,$J,358.3,41257,1,4,0)
+70 ;;=4^I15.8
+71 ;;^UTILITY(U,$J,358.3,41257,2)
+72 ;;=^5007074
+73 ;;^UTILITY(U,$J,358.3,41258,0)
+74 ;;=I15.9^^152^2031^17
+75 ;;^UTILITY(U,$J,358.3,41258,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,41258,1,3,0)
+78 ;;=3^Secondary Hypertension,Unspec
+79 ;;^UTILITY(U,$J,358.3,41258,1,4,0)
+80 ;;=4^I15.9
+81 ;;^UTILITY(U,$J,358.3,41258,2)
+82 ;;=^5007075
+83 ;;^UTILITY(U,$J,358.3,41259,0)
+84 ;;=I16.0^^152^2031^14
+85 ;;^UTILITY(U,$J,358.3,41259,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,41259,1,3,0)
+88 ;;=3^Hypertensive Urgency
+89 ;;^UTILITY(U,$J,358.3,41259,1,4,0)
+90 ;;=4^I16.0
+91 ;;^UTILITY(U,$J,358.3,41259,2)
+92 ;;=^8133013
+93 ;;^UTILITY(U,$J,358.3,41260,0)
+94 ;;=I16.1^^152^2031^7
+95 ;;^UTILITY(U,$J,358.3,41260,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,41260,1,3,0)
+98 ;;=3^Hypertensive Emergency
+99 ;;^UTILITY(U,$J,358.3,41260,1,4,0)
+100 ;;=4^I16.1
+101 ;;^UTILITY(U,$J,358.3,41260,2)
+102 ;;=^8204721
+103 ;;^UTILITY(U,$J,358.3,41261,0)
+104 ;;=I16.9^^152^2031^6
+105 ;;^UTILITY(U,$J,358.3,41261,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,41261,1,3,0)
+108 ;;=3^Hypertensive Crisis,Unspec
+109 ;;^UTILITY(U,$J,358.3,41261,1,4,0)
+110 ;;=4^I16.9
+111 ;;^UTILITY(U,$J,358.3,41261,2)
+112 ;;=^5138600
+113 ;;^UTILITY(U,$J,358.3,41262,0)
+114 ;;=A07.0^^152^2032^5
+115 ;;^UTILITY(U,$J,358.3,41262,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,41262,1,3,0)
+118 ;;=3^Balantidiasis
+119 ;;^UTILITY(U,$J,358.3,41262,1,4,0)
+120 ;;=4^A07.0
+121 ;;^UTILITY(U,$J,358.3,41262,2)
+122 ;;=^12533
+123 ;;^UTILITY(U,$J,358.3,41263,0)
+124 ;;=A07.1^^152^2032^9
